multiple myeloma
BostonGene, Sylvester Comprehensive Cancer Center Partner on Hematologic Cancer Molecular Subtyping
Researchers will compare traditional tumor profiling methods such as FISH and cytogenetics to BostonGene's AI-powered molecular and immune profiling platform.
Predicta Biosciences Raises $5.2M in Seed Round
The funding will be used to expand the company's team and build a CLIA laboratory and workflow for sequencing and bioinformatics.
Stemcell Technologies Cell Enrichment Kit Nabs FDA De Novo Classification
The kit can be used to enrich plasma cells expressing the CD138 marker from patient bone marrow samples.
Sebia Receives FDA 510(k) Clearance for FLC Kappa and Lambda Tests
The tests are for quantitative detection of kappa and lambda free light chains for diagnosing and monitoring multiple myeloma and immunoglobulin light-chain amyloidosis.
The Seattle-based company recently completed a strategic reorganization around its two major business areas by cutting the workforce and appointing a new CFO.
May 6, 2021
Natera Q1 Revenues Grow 62 Percent
Feb 26, 2020
Adaptive Biotechnologies Q4 Revenues Rise 41 Percent
Aug 14, 2019
Feb 15, 2018
Dec 13, 2017
Abingdon Health Raises £1.1M
Apr 18, 2017